Unraveling Caco-2 cells through functional and transcriptomic assessments.

Ye Eun Jeong1, Katherine Shea1, Kevin A Ford1

  • 1Division of Applied Regulatory Science, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, The U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.

Summary

The Caco-2 cell model effectively mimics the human intestinal barrier for drug permeability studies. However, significant gene expression differences limit its accuracy for predicting active drug transport and metabolism.